BMS-863233 (XL-413) 5mg
BMS-863233, also known as XL-413, is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity.
| Trivial name | BMS-863233 (XL-413) 5mg |
| Catalog Number | A13677-5 |
| Alternative Name(s) | (S)-8-chloro-2-(pyrrolidin-2-yl)benzofuro[3,2-d]pyrimidin-4(3H)-one hydrochloride |
| Molecular Formula | C14H13Cl2N3O2 |
| CAS# | 1169562-71-3 |
| SMILES | C1C[C@H](NC1)C2=NC(=O)C3=C(N2)C4=C(O3)C=CC(=C4)Cl.Cl |
| Size | 5mg |
| Supplier Page | http://www.adooq.com/bms-863233-xl-413.html |